Becton Dickinson and Company
Becton Dickinson and Company/ US0758871091 /
BDX
|
17/07/2024 16:41:13
|
Var.
+2.40
|
Volume |
Denaro16:41:17 |
Lettera16:41:17 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
233.10USD
|
+1.04%
|
282,337
Fatturato: 46.97 mill. |
233.03Quantità in denaro: 200 |
233.40Quantità in lettera: 400 |
67.36 bill.USD |
1.56% |
46.89 |
Descrizione business
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. The innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Tom Polen |
| Consiglio di amministrazione |
| Christopher DelOrefice, Ami Simunovich, Dave Hickey, David Shan, Elizabeth McCombs, Roland Goette, William R. Sigmund, II, Michelle Quinn, Shana Neal, Pavan Mocherla, Vishy Kanda, Michael Garrison, Denise Fleming, Tony Ezell, Richard Byrd, Herman Cueto, Jeff Silvestri |
| Consiglio di sorveglianza |
| Tom Polen, Bertram L. Scott, Timothy M. Ring, Marshall O. Larsen, Christopher Jones, Jeffrey W. Henderson, Claire M. Fraser, R. Andrew Eckert, Carrie Byington, Catherine M. Burzik, William M. Brown, Joanne Waldstreicher |
Dati aziendali
| Name: |
Becton, Dickinson and Company |
| Indirizzo: |
1 Becton Drive,Franklin Lakes, New Jersey 07414, USA |
| Telefono: |
+1-201-847-6800 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.bd.com |
| Industria: |
Healthcare |
| Settore: |
Medical Products |
| Sub settore: |
Advanced Medical Devices |
| Fine dell'anno finanziario: |
30/09 |
| Flottante libero: |
77.40% |
| Data dell'IPO: |
23/04/1962 |
